Provided by Tiger Trade Technology Pte. Ltd.

EyePoint

4.30
+0.06501.54%
Volume:890.37K
Turnover:3.78M
Market Cap:370.28M
PE:-1.14
High:4.34
Open:4.29
Low:4.16
Close:4.23
52wk High:19.11
52wk Low:3.95
Shares:86.21M
Float Shares:60.67M
Volume Ratio:0.60
T/O Rate:1.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7642
EPS(LYR):-3.1667
ROE:-148.70%
ROA:-74.85%
PB:2.23
PE(LYR):-1.36

Loading ...

Did EyePoint's (EYPT) Federal Settlement and 5‑Year Integrity Deal Just Reframe Its Risk Profile?

Simply Wall St.
·
Jul 28

Eyepoint Enters Settlement Agreement with DOJ, Oig-hhs, and DHA - SEC Filing

Reuters
·
Jul 18

EyePoint Pharmaceuticals Settles DEXYCU Case, Enhances Compliance Oversight

TIPRANKS
·
Jul 18

Eyepoint - to Pay $166,500 for Attorneys' Fees and Costs - SEC Filing

THOMSON REUTERS
·
Jul 18

Eyepoint - Enters Corporate Integrity Agreement with Oig-hhs on July 13, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 18

Eyepoint - to Pay $4.68 Mln Plus Interest in Settlement - SEC Filing

THOMSON REUTERS
·
Jul 18

Eyepoint - Enters Settlement Agreement with DOJ, Oig-hhs, and Dha on July 17, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 18

EyePoint to pay $4.6M to resolve False Claim Act allegations

TIPRANKS
·
Jul 17

Stifel Initiates EyePoint Pharmaceuticals at Buy With $40 Price Target

MT Newswires Live
·
Jul 16

Eyepoint Grants Inducement Stock Options for 63,500 Shares at $13.85 Each

Reuters
·
Jul 16

Eyepoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 16

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 16

Eyepoint Inc : Stifel Initiates Coverage with Buy Rating; Target Price $40

THOMSON REUTERS
·
Jul 16

Eyepoint Pharmaceuticals Initiated at Buy by Stifel

Dow Jones
·
Jul 16

EyePoint initiated with a Buy at Stifel

TIPRANKS
·
Jul 16

EyePoint (EYPT) Adds Retina Leadership, Is The 64% Undervaluation Case Convincing?

Simply Wall St.
·
Jul 14

Mizuho Securities Remains a Buy on EyePoint Pharmaceuticals (EYPT)

TIPRANKS
·
Jul 13

Eyepoint Appoints Tarek S. Hassan, M.d., as Chief Strategic Science Officer

THOMSON REUTERS
·
Jul 13

Press Release: Eyepoint Appoints Tarek S. Hassan, M.D., as Chief Strategic Science Officer

Dow Jones
·
Jul 13

Eyepoint Pharmaceuticals Coverage Assumed by Cantor Fitzgerald at Overweight

Dow Jones
·
Jul 08